A US insurance-claims study compared first-trimester doxycycline prescriptions and pregnancy loss in 218,234 pregnancies with respiratory infection and 6,636 with acne. For respiratory infections, risk was higher than with comparator antibiotics in both commercial insurance and Medicaid data. For acne, a difference appeared only in commercial insurance. The observational design cannot establish causation. Patients should tell clinicians about possible pregnancy and discuss alternatives without stopping or changing medication on their own.
Back to Health
Observational study links early-pregnancy doxycycline exposure with pregnancy loss
The study does not prove causation; patients should consult their prescriber rather than stop treatment themselves.